Injective is projected to decline to $4.48 by 2027, a -2% move from its current price of $4.89. INJ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.62 | $4.88 | $5.16 | -0.12% |
| Jul 14 | $4.51 | $4.88 | $5.27 | -0.24% |
| Jul 15 | $4.43 | $4.87 | $5.36 | -0.35% |
| Jul 16 | $4.36 | $4.87 | $5.43 | -0.47% |
| Jul 17 | $4.30 | $4.86 | $5.50 | -0.59% |
| Jul 18 | $4.24 | $4.86 | $5.56 | -0.71% |
| Jul 19 | $4.19 | $4.85 | $5.61 | -0.83% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.19 | $4.85 | $5.61 | -0.83% |
| Week 2 | $3.91 | $4.81 | $5.91 | -1.64% |
| Week 3 | $3.71 | $4.77 | $6.14 | -2.46% |
| Week 4 | $3.54 | $4.73 | $6.33 | -3.26% |
| Week 5 | $3.39 | $4.69 | $6.50 | -4.06% |
| Week 6 | $3.26 | $4.65 | $6.65 | -4.85% |
| Week 7 | $3.14 | $4.61 | $6.78 | -5.64% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.
The asset is categorized across multiple ecosystems and sectors, including Cosmos Ecosystem, Layer 1, Decentralized Finance (DeFi), and Smart Contract Platform. These designations reflect its positioning as a cross-chain capable blockchain intended to support on-chain financial activity.
Injective sits within a broad portfolio of related ecosystems and networks, underscoring its role in the DeFi and Layer 1 space while emphasizing interoperability and cross-chain functionality.
Injective (INJ) is currently priced at $4.81. It ranks 109 by market cap, with a market capitalization of $481.31M.
The all-time high for INJ is $52.62, illustrating substantial historical upside from its current level. The forecast shows a multi-year upside path, with average prices climbing from $4.59 in 2026 to $317.64 in 2050, and a max forecast reaching as high as $730.58 by 2050.
Across 2026–2050, the model projects a wide range of outcomes, with 2028 averaging $12.58 and 2040 averaging $100.34, then rising further to an average of $317.64 in 2050. The maximum forecasts extend to $98.52 in some mid-years and up to $730.58 in 2050, underscoring the potential for substantial upside alongside notable volatility. The implied ROI grows from 0% in 2026 to a long-run high of 6820.4% in 2050, with bullish sentiment in the later years.
A major floor 46.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.9% below — buyers have tended to step in here.
The nearest ceiling, 42.9% above — a clean break opens room to run.
A major ceiling 61.3% above — clearing it would confirm fresh momentum.
Key INJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.67 | Buy | $4.62 | Buy |
| MA 10 | $4.60 | Buy | $4.70 | Buy |
| MA 20 | $4.96 | Sell | $4.89 | Buy |
| MA 50 | $5.26 | Sell | $4.91 | Sell |
| MA 100 | $4.28 | Buy | $4.66 | Buy |
| MA 200 | $4.13 | Buy | $5.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.18 | Neutral |
| Stoch RSI (14) | 53.90 | Neutral |
| CCI (20) | -69.49 | Neutral |
| Williams %R (14) | -72.29 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -14.69 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 27.71 | Neutral |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | -0.66 | Sell |
| Ultimate (7,14,28) | 43.30 | Neutral |
| Momentum (10) | -0.46 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 4.67 | Buy |
| ADX (14) | 15.60 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture is bullish overall. The sentiment is labeled BULLISH, with the RSI(14) at 40, suggesting room to move before reaching overbought levels.
The short-term moving averages show the SMA50 at $5.26 and the SMA200 at $4.13. Support sits at $4.26 and resistance is indicated at $6.99, framing a potential drift within a $3.40–$6.20 30-day range. Traders may watch for a move toward the resistance as momentum builds.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.74 | $4.59 | $5.06 | 0% | Neutral | |
| $3.25 | $4.48 | $6.70 | -2% | Neutral | |
| $8.57 | $12.58 | $20.02 | +174% | Bullish | |
| $12.33 | $19.07 | $31.86 | +316% | Bullish | |
| $8.88 | $14.39 | $25.03 | +214% | Bullish | |
| $8.60 | $14.58 | $26.25 | +218% | Bullish | |
| $18.07 | $31.95 | $59.29 | +596% | Bullish | |
| $24.09 | $44.36 | $84.61 | +866% | Bullish | |
| $26.29 | $50.38 | $98.52 | +998% | Bullish | |
| $22.82 | $45.45 | $90.96 | +890% | Bullish | |
| $45.15 | $100.34 | $220.67 | +20.9x | Bullish | |
| $142.94 | $317.64 | $730.58 | +68.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.74 | $4.59 | $6.53 | -6.13% |
| August 2026 | $4.33 | $5.27 | $6.71 | +14.90% |
| September 2026 | $3.56 | $4.39 | $5.69 | -16.77% |
| October 2026 | $3.31 | $4.14 | $5.46 | -5.72% |
| November 2026 | $3.47 | $4.38 | $5.85 | +5.83% |
| December 2026 | $2.93 | $3.74 | $5.06 | -14.68% |
Click any year to see its month-by-month INJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Injective's 2026 outlook centres on $4.59, within a $2.74 to $5.06 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, INJ could reach as high as $6.70, with a base case around $4.48 and support toward $3.25 — roughly -2% from $4.89. A consolidation phase looks the most probable path here.
Expect INJ to range from $8.57 to $20.02 through 2028. The $12.58 average target implies a +174% move from current prices. That is up +180% on the projected 2027 average. Momentum favours further upside here.
The INJ price prediction for 2029 points to an average of $19.07 (low $12.33, high $31.86) — a potential gain of +316% on today's $4.89. Buyers look set to stay in control over this stretch.
In 2030, INJ is projected to trade between $8.88 and $25.03, averaging $14.39 — a potential gain of +214% from today's $4.89. That is -25% versus the projected 2029 average. Momentum favours further upside here.
Injective's 2031 outlook centres on $14.58, within a $8.60 to $26.25 range. That is up +1% on the projected 2030 average. That marks a +218% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, INJ could reach as high as $59.29, with a base case around $31.95 and support toward $18.07 — roughly +596% from $4.89. Momentum favours further upside here.
Expect INJ to range from $24.09 to $84.61 through 2033. The $44.36 average target implies a +866% move from current prices. That is up +39% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The INJ price prediction for 2034 points to an average of $50.38 (low $26.29, high $98.52) — a potential gain of +998% on today's $4.89. Momentum favours further upside here.
In 2035, INJ is projected to trade between $22.82 and $90.96, averaging $45.45 — a potential gain of +890% from today's $4.89. That is -10% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Injective's 2040 outlook centres on $100.34, within a $45.15 to $220.67 range. That is up +121% on the projected 2035 average. That marks a +20.9x change versus current levels. Momentum favours further upside here.
By 2050, INJ could reach as high as $730.58, with a base case around $317.64 and support toward $142.94 — roughly +68.2x from $4.89. Buyers look set to stay in control over this stretch.
Investing $1,000 in INJ today (≈ 204.498978 INJ) could be worth
$64,957.92
+$63,957.92 (+6396%) by 2050 · US Dollar
Based on the average projected INJ price of $317.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INJwould be worth at today's price.
$1,000 invested in INJ on Jul 1, 2025 (≈ 92.89996 INJ) would be worth
$454.28
-$545.72 (-54.6%) today · 0.45× · US Dollar
Based on a INJ entry price of $10.76 vs. today's $4.89.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.54 | $1,077.35 | +7.7% |
| 1 month ago | $6.51 | $750.93 | -24.9% |
| 3 months ago | $2.87 | $1,703.6 | +70.4% |
| 6 months ago | $4.53 | $1,079.8 | +8.0% |
| 1 year ago | $10.76 | $454.28 | -54.6% |
| All time (1.1y) ago | $14.05 | $348.01 | -65.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INJ forecast.
Our base-case forecast reaches $9.80 around 2028.
Implied market cap at $9.80: $980M
The multi-year forecast points to a bullish trajectory with meaningful upside across the late 2020s into the 2030s and beyond. In 2030, the average price is projected at $14.39 with a min of $8.88 and a max of $25.03, yielding an estimated ROI of 213.6% and a bullish sentiment.
In 2040, the average is forecast at $100.34, with a max of $220.67 and an ROI of 2086.1%, again signaling strong upside potential under the bullish scenario.
In 2050, the average is projected at $317.64 with a max of $730.58 and an ROI of 6820.4%, maintaining the bullish outlook. These figures illustrate substantial long-run upside but are not guaranteed and depend on market conditions and other factors. Investors should be aware of the inherent uncertainty and volatility in such forecasts.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $14.39 with a min of $8.88 and a max of $25.03. The projected ROI is 213.6% and the sentiment is BULLISH.
Forecasts indicate upside in several years, including 2028 with an average of $12.58 (ROI 174%) and 2029 with an average of $19.07 (ROI 315.5%). These are estimates and not guarantees.
Yes—the 2040 forecast shows an average price near $100.34 with a max of $220.67. The projected ROI is 2086.1% and the sentiment is BULLISH.
Injective is currently priced at $4.81. Its market capitalization is $481.31M and the all-time high is $52.62.
The all-time high is $52.62. This provides a historical reference point against which the current price and forecasted upside can be considered.
Injective Community Discussion
0Share your Injective price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.